학술논문
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients
Document Type
Article
Author
Source
In: Leukemia . (Leukemia, July 2024, 38(7):1494-1500)
Subject
Language
English
ISSN
14765551
08876924
08876924